OBJECTIVES: To determine the rate of CD4 decline and the incidence of opportunistic infections (OIs) among antiretroviral therapy-naive South African HIV-infected patients and inform timing of OI prophylaxis. METHODS: We used mixed-effect models to estimate CD4 cell decline by CD4 cell count strata in HIV-infected patients in the Cape Town AIDS Cohort between 1984 and 2000. Stratum-specific OI incidence per 100 person-years of observation was determined using incidence density analysis. RESULTS: Nine hundred seventy-four patients with 2 or more CD4 cell counts were included. CD4 counts declined by 47.1 cells/microL per year in the stratum with more than 500 cells/microL stratum, 30.6 cells/microL per year in the stratum with 351 to 500 cells/microL, and 20.5 cells/microL per year in the stratum with 201 to 350 cells/microL. Tuberculosis and oral candidiasis were the only OIs that occurred frequently in the stratum with more than 200 CD4 cells/microL. Rates of chronic diarrhea, wasting syndrome, tuberculosis, and oral and esophageal candidiasis increased in the stratum with less than 200 cells/microL, and rates of all OIs were highest in the stratum with 50 cells/microL or less. CONCLUSIONS: : CD4 cell count declines were dependent on CD4 strata and can inform timing of clinic visits and treatment initiation in South Africa. Incidence rates of OIs suggest that targeted OI prophylaxis could prevent substantial HIV-related morbidity in South Africa.
OBJECTIVES: To determine the rate of CD4 decline and the incidence of opportunistic infections (OIs) among antiretroviral therapy-naive South African HIV-infectedpatients and inform timing of OI prophylaxis. METHODS: We used mixed-effect models to estimate CD4 cell decline by CD4 cell count strata in HIV-infectedpatients in the Cape Town AIDS Cohort between 1984 and 2000. Stratum-specific OI incidence per 100 person-years of observation was determined using incidence density analysis. RESULTS: Nine hundred seventy-four patients with 2 or more CD4 cell counts were included. CD4 counts declined by 47.1 cells/microL per year in the stratum with more than 500 cells/microL stratum, 30.6 cells/microL per year in the stratum with 351 to 500 cells/microL, and 20.5 cells/microL per year in the stratum with 201 to 350 cells/microL. Tuberculosis and oral candidiasis were the only OIs that occurred frequently in the stratum with more than 200 CD4 cells/microL. Rates of chronic diarrhea, wasting syndrome, tuberculosis, and oral and esophageal candidiasis increased in the stratum with less than 200 cells/microL, and rates of all OIs were highest in the stratum with 50 cells/microL or less. CONCLUSIONS: : CD4 cell count declines were dependent on CD4 strata and can inform timing of clinic visits and treatment initiation in South Africa. Incidence rates of OIs suggest that targeted OI prophylaxis could prevent substantial HIV-related morbidity in South Africa.
Authors: S D Lawn; A D Harries; B G Williams; R E Chaisson; E Losina; K M De Cock; R Wood Journal: Int J Tuberc Lung Dis Date: 2011-05 Impact factor: 2.373
Authors: Elena Losina; Peter Figueroa; Jacqueline Duncan; Nomita Divi; Lindsey L Wolf; Lisa R Hirschhorn; Minnette Robertson; Kevin Harvey; Sheldon Whorms; Kenneth A Freedberg; Yitades Gebre Journal: Int J Infect Dis Date: 2007-08-13 Impact factor: 3.623
Authors: John Mansoer; Suzanne Scheele; Katherine Floyd; Christopher Dye; Joseph Sitienei; Brian Williams Journal: Bull World Health Organ Date: 2009-03 Impact factor: 9.408
Authors: Rochelle P Walensky; Eric L Ross; Nagalingeswaran Kumarasamy; Robin Wood; Farzad Noubary; A David Paltiel; Yoriko M Nakamura; Sheela V Godbole; Ravindre Panchia; Ian Sanne; Milton C Weinstein; Elena Losina; Kenneth H Mayer; Ying Q Chen; Lei Wang; Marybeth McCauley; Theresa Gamble; George R Seage; Myron S Cohen; Kenneth A Freedberg Journal: N Engl J Med Date: 2013-10-31 Impact factor: 91.245
Authors: Eran Bendavid; Sean D Young; David A Katzenstein; Ahmed M Bayoumi; Gillian D Sanders; Douglas K Owens Journal: Arch Intern Med Date: 2008-09-22
Authors: Noah Kiwanuka; Merlin Robb; Oliver Laeyendecker; Godfrey Kigozi; Fred Wabwire-Mangen; Fredrick E Makumbi; Fred Nalugoda; Joseph Kagaayi; Michael Eller; Leigh Anne Eller; David Serwadda; Nelson K Sewankambo; Steven J Reynolds; Thomas C Quinn; Ronald H Gray; Maria J Wawer; Christopher C Whalen Journal: J Acquir Immune Defic Syndr Date: 2010-06 Impact factor: 3.731
Authors: Eran Bendavid; Robin Wood; David A Katzenstein; Ahmed M Bayoumi; Douglas K Owens Journal: J Acquir Immune Defic Syndr Date: 2009-09-01 Impact factor: 3.731